HOME › DRUGS › ELETRIPTAN HYDROBROMIDE
ACTIVE SUBSTANCE / INN

ELETRIPTAN HYDROBROMIDE

Brand name(s): RELPAX, ELETRIPTAN HYDROBROMIDE
FDA LISTED
PRESCRIPTION
DISCONTINUED
NONE (TENTATIVE APPROVAL)
ANDA215467
ANDA201536
ACTIVE SUBSTANCE
Eletriptan Hydrobromide
REGULATORS
FDA
SPONSORS / MAH
UPJOHN, REGCON HOLDINGS, CARLSBAD
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ELETRIPTAN HYDROBROMIDEANDA215467REGCON HOLDINGSPrescription
ELETRIPTAN HYDROBROMIDEANDA209680CARLSBADDiscontinued
ELETRIPTAN HYDROBROMIDEANDA201536APOTEX INCNone (Tentative Approval)
RELPAXNDA021016UPJOHNPrescription

FULL INTELLIGENCE ON ELETRIPTAN HYDROBROMIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →